Home › Funds › D. E. Shaw & Co › CYTK
D. E. Shaw & Co position in CYTK
CYTOKINETICS INC · Health Care
Latest position (Q2 2026)1.05M sh
Reported value held$89.29M
Portfolio Weight0.05%
First reportedQ4 2021
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2021 | 106.28K | $4.84M | New |
| Q3 2022 | 41.94K | $2.03M | New |
| Q3 2023 | 27.33M | $23.21M | New |
| Q4 2023 | 29.33M | $51.88M | Add |
| Q1 2024 | 100.85K | $7.07M | Reduce |
| Q2 2024 | 119.30K | $6.46M | Add |
| Q3 2024 | 131.09K | $6.92M | Add |
| Q4 2024 | 84.30K | $3.97M | Reduce |
| Q1 2025 | 86.00K | $3.46M | Add |
| Q2 2025 | 128.48K | $4.25M | Add |
| Q3 2025 | 104.70K | $5.75M | Reduce |
| Q4 2025 | 200.72K | $12.75M | Add |
| Q1 2026 | 747.33K | $49.26M | Add |
| Q2 2026 | 1.05M | $89.29M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding CYTK
- BlackRock Inc 20.09M sh · $1.71B · Q2 2026
- Vanguard Group 12.05M sh · $765.54M · Q4 2025
- Geode Capital Management 3.71M sh · $316.33M · Q2 2026
- Citadel Advisors 1.97M sh · $167.55M · Q2 2026
- Capital Research Global Investors 1.69M sh · $143.68M · Q2 2026
- Northern Trust Corp 1.65M sh · $140.34M · Q2 2026
- Point72 Asset Management 1.59M sh · $135.31M · Q2 2026
- Charles Schwab Investment Management 1.57M sh · $133.39M · Q2 2026
- Principal Global Investors 1.31M sh · $111.74M · Q2 2026
- Invesco Ltd 1.24M sh · $105.24M · Q2 2026
- UBS Group AG 1.17M sh · $99.78M · Q2 2026